Healthcare Stocks 2020: Major Diagnosis Change
With the COVID-19 epidemic sweeping the globe, healthcare’s critical role in developing innovative new drugs, devices, delivery systems etc. for massive unmet needs is refueling investor interest.
With the COVID-19 epidemic sweeping the globe, healthcare’s critical role in developing innovative new drugs, devices, delivery systems etc. for massive unmet needs is refueling investor interest.
It’s understandable that investing nerves are frayed. While the storm is very dark now, recoveries can happen very quickly. Time is the most powerful equalizer and markets have always recovered.
A bear market was made official last Thursday when the S&P 500 quickly fell below the -20% drop threshold. In the weeks leading up to the bear market and the past couple of days, volatility has raged with many investors asking how much worse could it get and is this the market bottom?
Managing your own portfolio can be a challenge especially in times of stock market stress like now. A broader context of market history during these volatile, stressor markets can be helpful.
When a global virus occurs, fear tends to spread faster than the virus itself. The good news is that the markets and economy will eventually get better. The not-so-good news is, like the coronavirus, there’s no defined timetable for it to occur.
The government is at it again, trying to “help us” with new legislation, this time signing into law sweeping changes to retirement savings. The law is intended to positively impact American’s ability to save but it also includes an unfavorable change for many planning to leave a retirement nest egg to their beneficiaries.